Vemurafenib and panitumumab combination tailored therapy in BRAF-mutated metastatic colorectal cancer: A case report

As the knowledge on cancer genetic alterations progresses, it fosters the need for more personalized therapeutic intervention in modern cancer management. Recently, mutations in KRAS, BRAF, and PIK3CA genes have emerged as important mechanisms of resistance to EGFR-targeted therapy in metastatic col...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Capalbo, Carlo, Marchetti, Paolo, Coppa, Anna, Calogero, Antonella, Anastasi, Emanuela, Buffone, Amelia, Belardinilli, Francesca, Gulino, Matteo, Frati, Paola, Catalano, Carlo, Cortesi, Enrico, Giannini, Giuseppe, Gulino, Alberto
Médium: Artigo
Jazyk:Inglês
Vydáno: Landes Bioscience 2014
Témata:
Bedside to Bench Report
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4100983/
https://ncbi.nlm.nih.gov/pubmed/24755613
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/cbt.28878
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky